437
Participants
Start Date
June 21, 2019
Primary Completion Date
August 29, 2025
Study Completion Date
August 29, 2025
Nivolumab
Specified dose on specified days
Ipilimumab
Specified dose on specified days
Ipilimumab placebo
Specified dose on specified days
Local Institution - 0031, Vienna
Local Institution - 0011, Ciudad Autónoma de Buenos Aires
Local Institution - 0100, Capital Federal
Local Institution - 0032, Wels
Local Institution - 0002, San Juan
Local Institution - 0025, Río Cuarto
Local Institution - 0060, Mar del Plata
Local Institution - 0033, Graz
Local Institution - 0071, Marseille
Local Institution - 0042, Córdoba
Local Institution - 0094, Caen
Local Institution - 0009, Mexico City
Local Institution - 0010, Mexico City
Local Institution - 0023, Athens
Local Institution - 0044, Santiago Compostela
The Reading Hosp Med Ctr Reg Cancer Ctr, West Reading
Local Institution - 0013, Washington D.C.
Local Institution - 0021, Milan
Local Institution - 0075, Besançon
Local Institution - 0082, Brescia
Local Institution - 0036, Madrid
Local Institution - 0035, Madrid
Local Institution - 0084, Charleston
Local Institution - 0074, Brest
Local Institution - 0053, Athens
Local Institution - 0008, Chihuahua City
Local Institution - 0045, Pamplona
Local Institution - 0016, Aviano (PN)
Local Institution - 0080, La Tronche
Local Institution - 0043, Santander
Local Institution - 0041, Seville
Local Institution - 0024, Larissa
Local Institution - 0015, Parma
Local Institution - 0040, Valencia
Local Institution - 0073, Angers
Local Institution - 0069, Angers
Local Institution - 0014, Arezzo
Local Institution - 0078, Nancy
Local Institution - 0091, Valenciennes
Local Institution - 0067, Monterrey
Local Institution - 0093, Strasbourg
Local Institution - 0092, Paris
Local Institution - 0046, Querétaro
Local Institution - 0081, Hyères
Local Institution - 0072, Suresnes
Local Institution - 0068, Villejuif
Local Institution - 0054, Saint Petersburg
Local Institution - 0065, Craiova
Local Institution - 0056, Cluj-Napoca
Local Institution - 0058, Novosibirsk
Local Institution - 0004, Viña del Mar
Local Institution - 0003, Santiago
Local Institution - 0034, Santiago
Local Institution - 0066, Boston
Local Institution - 0088, Boston
Local Institution - 0086, Boston
Local Institution - 0001, Viedma
Local Institution - 0005, Córdoba
Local Institution - 0012, Viña El Mar
Local Institution - 0017, Independencia
Local Institution - 0020, Brno
Local Institution - 0097, Brno
Local Institution - 0019, Prague
Local Institution - 0018, Prague
Local Institution - 0096, Nice
Local Institution - 0077, Roma
Local Institution - 0006, Mexico City
Local Institution - 0030, Biała Podlaska
Local Institution - 0095, Bydgoszcz
Local Institution - 0062, Bytom
Local Institution - 0026, Gdansk
Local Institution - 0029, Poznan
Local Institution - 0027, Warsaw
Local Institution - 0050, Lisbon
Local Institution - 0061, Bucharest
Local Institution - 0038, Barcelona
Local Institution - 0037, Barcelona
Local Institution - 0039, Sabadell
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY